Biomarker study detects onset of Alzheimer’s up to 30 years before symptoms appear

Unfortunately, we do not have any clear diagnostic framework to identify the disease at its earliest stage. Blood tests, PET scans, eye tests, genetics, and even sniff tests, are all being investigated as ways to identify the earliest stages of cognitive decline, but no single biomarker has been wholly confirmed as clinically reliable so far.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.